Nephrotoxicity: Clinical Trials

22 trials for Nephrotoxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 5 unknown, 4 recruiting, 3 not yet recruiting. 7 Phase 2, 4 Phase 3, 3 Phase 4, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 27Completed 3, Recruiting 3, Not yet recruiting 1
Phase 34Not yet recruiting 2, Active not recruiting 1, Completed 1
Phase 43Unknown 2, Completed 1
Not applicable2Enrolling by invitation 1, Unknown 1

Follow Nephrotoxicity: new trials by email Literature Review of Nephrotoxicity trials Research Report on Nephrotoxicity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rutin and Ascorbic Acid for Prevention of Vancomycin-Induced Nephrotoxicity in Adult Patients" - a Clinical Trial Protocol Evaluating Whether Combined Rutin/Vitamin C Supplementation Reduces Kidney Toxicity From Vancomycin, Compared to Vitamin C Alone and Control.
Rutin + Ascorbic Acid (RUTA C60®), Ascorbic Acid (C-Retard®) - Nephrotoxicity, Acute Kidney Injuries
Not applicableEnrolling by invitationAin Shams University1202026-10-012026-10-14
Differentiating True Nephrotoxicity From Pseudo-nephrotoxicity: A Prospective Comparative Study of Vancomycin Plus Piperacillin-Tazobactam vs. Meropenem Using Serum Creatinine and Cystatin-C
Nephrotoxicity, Bacterial Infections
Not yet recruitingKing Faisal Specialist Hospital & Research Center3042026-09-152026-09-14
Colistin Nephrotoxicity and Role of Alpha Lipoic Acid
alpha lipoic acid drug (thioctic acid acid) - Nephrotoxicity
Phase 3Not yet recruitingHelwan University882026-06-302026-06-25
Renoprotective Role of Vitamin C and Coenzyme Q10 in Nephrotoxicity
Vitamin C, Coenzyme Q 10 - Nephrotoxicity
Phase 2 / Phase 3Not yet recruitingAin Shams University752026-04-202026-03-17
Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity
Alpha-Lipoic Acid (ALA) - Cisplatin Nephrotoxicity, Nephrotoxicity
Phase 2RecruitingMinia University502026-03-102026-05-04
L-Carnitine Protective Effect in Nephrotoxicity
L-Carnitine Tartrate, Placebo - Nephrotoxicity
Phase 2RecruitingTanta University462025-08-102025-08-12
Efficacy and Safety of N-Acetylcysteine Versus Alpha-Lipoic Acid in Colistin-Induced Nephrotoxicity
Addition of sachets of N-acetyl cysteine 1200 mg twice/day to the maintenance dose of colistin, Addition of Alpha-lipoic acid 600mg twice daily to the maintenance dose of colistin - Nephrotoxicity
Phase 2 / Phase 3CompletedAin Shams University1802024-11-012026-02-17
Integrated Learning Support System Based on Immersive Simulated Training for Nursing Students
Integrated Learning Support System, Standard Learning Model - Simulation Training, Learning
Not applicableUnknownUniversity of Brasilia952024-08-012024-07-31
KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)
Childhood Cancer, Chronic Kidney Diseases
RecruitingThe Hospital for Sick Children5002024-01-052024-04-17
Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.
Huaier Granule, VEGFR-TKIs - Nephrotoxicity
Phase 2CompletedFudan University762023-01-032026-02-09
Clinical Outcomes in Adult Patients Undergoing Laparoscopic Surgery Under Neuraxial Anesthesia
Mortality, Surgical Complication
UnknownAsst Melegnano e Martesana702022-10-012024-04-11
Cisplatin Disposition and Kidney Injury
Granisetron, Ondansetron, Palonosetron - Nephrotoxicity
Phase 3Active not recruitingUniversity of Colorado, Denver452019-11-152026-09-17
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Tempol, Placebo Solution - Mucositis, Nephrotoxicity
Phase 2RecruitingMatrix Biomed, Inc.1202019-05-132024-11-20
Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin to Predict AKI in the NICU
urine neutrophil gelatinase -associated lipocalin - Acute Kidney Injury, Nephrotoxicity
CompletedUniversity of Alabama at Birmingham1482019-01-282024-01-05
Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients
Vancomycin Continuous infusion, Vancomycin Intermittent infusion - Gram-Positive Bacterial Infections, Nephrotoxicity
Phase 4UnknownUniversity of Sao Paulo2222018-04-282018-04-05
Assessment of Urinary NGAL to Predict AKI in Children Receiving Multiple Nephrotoxic Medications
Acute Kidney Injury, Nephrotoxicity
CompletedChildren's Hospital Medical Center, Cincinnati1342018-04-232021-10-05
0,9% NaCl Effect on Kidney Function and Glycocalyx in Patients Operated on for Primary Hiparthrosis
Plasma-lyte, 0,9% saline - Nephrotoxicity
Phase 4UnknownRegional Hospital Holstebro402015-03-012015-08-19
Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients
Belatacept - Nephrotoxicity
Phase 4CompletedIndiana University62014-06-012017-08-28
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Pantoprazole, High-dose methotrexate infusion duration - Osteosarcoma, Nephrotoxicity
Phase 2CompletedChildren's Hospital of Philadelphia132013-04-012020-03-16
Aminoglycoside Plasma Level Measurement in Neonates With Infection
Nephrotoxicity, Ototoxicity
UnknownUniversitas Indonesia252010-11-012012-07-10

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Acute Kidney Injury (5)  ·  Neoplasms (3)  ·  Ototoxicity (3)  ·  Bacterial Infections (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Hypertension (1)  ·  Mucositis (1)  ·  Osteosarcoma (1)  ·  Proteinuria (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)  ·  Sepsis (1)

Broader conditions

Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Male Urogenital Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Urogenital Diseases (6)  ·  Urologic Diseases (6)  ·  Kidney Diseases (5)  ·  Pathologic Processes (5)  ·  Renal Insufficiency (4)  ·  Chemically-Induced Disorders (3)  ·  Drug-Related Side Effects and Adverse Reactions (3)  ·  Ear Diseases (3)  ·  Otorhinolaryngologic Diseases (3)  ·  Radiation Injuries (3)  ·  Wounds and Injuries (3)

Interventions

Ascorbic Acid (2)  ·  Thioctic Acid (2)  ·  Abatacept (1)  ·  Carnitine (1)  ·  Granisetron (1)  ·  Methotrexate (1)  ·  Ondansetron (1)  ·  Palonosetron (1)  ·  Pantoprazole (1)  ·  Plasma-lyte 148 (1)  ·  Rutin (1)  ·  Sodium Chloride (1)  ·  coenzyme Q10 (1)  ·  tempol (1)

Sponsors

Ain Shams University (3)  ·  Asst Melegnano e Martesana (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Children's Hospital of Philadelphia (1)  ·  Fudan University (1)  ·  Helwan University (1)  ·  Indiana University (1)  ·  King Faisal Specialist Hospital & Research Center (1)  ·  Matrix Biomed, Inc. (1)  ·  Minia University (1)  ·  Regional Hospital Holstebro (1)  ·  Tanta University (1)  ·  The Hospital for Sick Children (1)  ·  Universitas Indonesia (1)  ·  University Hospital, Geneva (1)

Countries

United States (7)  ·  Egypt (6)  ·  Brazil (2)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Indonesia (1)  ·  Italy (1)  ·  Saudi Arabia (1)

Top investigators

Ahmed Mostafa Abd-Elaziz (1)  ·  Amal Kamal Hussein (1)  ·  Asif Sharfuddin, MD (1)  ·  Asmaa Basem Mohammed (1)  ·  Benji Crane (1)  ·  Breno S Santana, MsC (1)  ·  David Askenazi (1)  ·  Dina H El Adly, MSc (1)  ·  Edgar Jaimes, MD (1)  ·  Eman Magdy Elsayed Elyamany, Assistant lecturer (1)  ·  Eman Mohamed Sadek (1)  ·  Erling B Perdersen, MD, DMSc (1)  ·  Estela M de Oliveira, PhD student (1)  ·  Fatma M Eweda, Master (1)  ·  Frank M Balis, MD (1)

Results publications

PMID 23557866, PMID 23731573, PMID 29445029, PMID 33677616, PMID 33771116, PMID 38151013, PMID 38955285, PMID 39711135, PMID 39726772

NIH funding

R01GM123330 (1)